## Abstract ## BACKGROUND The authors evaluated the efficacy of chemotherapy combined with rituximab followed by highβdose therapy (HDT) plus autologous stem cell transplantation in patients with mantle cell lymphoma (MCL). ## METHODS This was a retrospective analysis of 34 patients who were tre
Ventricular tachycardia associated with infusion of rituximab in mantle cell lymphoma
β Scribed by Yukihiro Arai; Jiro Tadokoro; Kinuko Mitani
- Publisher
- John Wiley and Sons
- Year
- 2005
- Tongue
- English
- Weight
- 104 KB
- Volume
- 78
- Category
- Article
- ISSN
- 0361-8609
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## BACKGROUND. Relapsed or refractory mantle cell lymphoma has a very poor prognosis. The authors evaluated the response rates and survival times of patients treated with an intense regimen known to be effective against untreated aggressive mantle cell lymphoma: rituximab plus hyperβCV
## Abstract In mantle cell lymphoma (MCL), a blastoid variant with a striking tendency to harbor chromosome numbers in the tetraploid range has been identified. Centrosome aberrations have recently been implicated in the induction of aneuploidy in many human malignancies including MCL by malsegrega